Tag: drugs

Coupled with the evolving US Food and Drug Administration manufacturing reforms, the deal underscores a policy-driven shift

The investment strengthens Peptris’ proposition as one of the leading Indian AI drug discovery platforms progressing beyond molecule generation towards clinical-ready assets

93% of global businesses cover weight-management drugs in their healthcare plans

The collaboration will also include jointly organized seminars, and technical training programs

New AI framework mimics real-world chemical synthesis to generate drug candidates that are both novel and lab-ready, offering faster routes to cancer and antibiotic resistance therapies

Three-day technical meet to feature hands-on training, case studies, and global regulatory dialogues

The Cover Story analyses the potential impact of significant uncertainty due to the proposed reciprocal tariffs with insights from Vishal Dhikale, Associate Vice President, Avalon Consulting. Read interview of Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia and Expert Insights by Mahesh Ramanujam, President & CEO, Global Network for Zero; and Dr Vidhi Bhanushali, CEO and Co-founder, scanO.

The Cover Story analyzes the blockbuster opportunity for India's biopharma industry. Read interviews of Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited; Sachin Joshi, MD & Founder, PharmNXT Biotech; Mandeep Singh Kumar, MD and Vice President, Medtronic India; and Harshvardhan Bhagchandka, President, IPL Biologicals

The company has a pipeline of over 25 products to be launched in US and European markets in the current year

According to GlobalData’s Pharma Intelligence Center Grants Database, SBIR and STTR grants involving innovator drugs saw a 37% increase in total grant value from $237 million in 2020 to $326 million in 2024